Reuters: Health
Bristol-Myers Squibb Co on Friday said it won a $752 million jury verdict against Gilead Sciences Inc in a U.S. patent dispute relating to technology for treating cancer.
Bristol-Myers wins $752 million in U.S. patent case against Gilead
Bristol-Myers wins $752 million in U.S. patent case against Gilead
Reuters: Health
Bristol-Myers Squibb Co on Friday said it won a $752 million jury verdict against Gilead Sciences Inc in a U.S. patent dispute relating to technology for treating cancer.
Reuters: Health
Bristol-Myers Squibb Co on Friday said it won a $752 million jury verdict against Gilead Sciences Inc in a U.S. patent dispute relating to technology for treating cancer.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment